课题基金 / 基金详情

Modulating calcineurin Signaling pathways in Muscle

Modulating calcineurin Signaling pathways in Muscle
调节肌肉中的钙调磷酸酶信号通路
批准号:
6830119
负责人:
Beverly A Rothermel
金额:
$35.1万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-13 至 2007-11-30

项目摘要

项目成果

Beverly A Rothermel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. 3alcineurin is a calcium regulated serine/threonine protein phosphatase. The calcineurin signal transduction pathway is involved in developmental and homeostatic regulation of a wide variety of cell types. We have recently described a new family of proteins that are enriched in heart and skeletal muscle called Modulatory Calcineurin-lnteracting Proteins (MCIPs). These proteins can form a physical complex with the active site of calcineurin and inhibit phosphatase activity. In turn, transcription of the mammalian MCIP1 gene is activated by calcineurin. Our goals are driven by the primary hypothesis that the MCIP family of proteins function as endogenous modulators of calcineurin activity. In initial studies we have shown that transgenic mice with elevated expression of human MCIP1 in cardiomyocytes are resistant to a variety of hypertrophic stimuli. Future development of measures to increase expression or activity of MCIP proteins selectively within the heart may have clinical value for prevention of heart failure. The goals of this grant are: 1) To define the interaction of MCIP with calcineurin, 2) To examine changes in the expression of MCIP genes and in the level of MCIPprotein during cardiac and skeletal muscle remodeling in order to refine our model integrating MCIP transcription, MCIP protein stability and calcineurin activity 3) To examine the cardioprotective potential of MCIPs and test our model that MCIPs are endogenous regulators of calcineurin signaling. These studies will clarify the mechanism, regulation and physiological role of MCIP proteins and create the basis for novel therapeutic approaches to regulating calcineurin. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elevated mitochondrial fusion and function in Down syndrome - Revision - 2
  • 批准号:
    10645484
  • 项目类别:
  • 资助金额:
    $16.49万
  • 财政年份:
    2022
  • 负责人:
    Beverly A Rothermel
  • 依托单位:
Elevated mitochondrial fusion and function in Down syndrome
  • 批准号:
    9894475
  • 项目类别:
  • 资助金额:
    $202.19万
  • 财政年份:
    2019
  • 负责人:
    Beverly A Rothermel
  • 依托单位:
Training Core
  • 批准号:
    10473538
  • 项目类别:
  • 资助金额:
    $15.96万
  • 财政年份:
    2015
  • 负责人:
    Beverly A Rothermel
  • 依托单位:
Training Core
  • 批准号:
    10684156
  • 项目类别:
  • 资助金额:
    $15.96万
  • 财政年份:
    2015
  • 负责人:
    Beverly A Rothermel
  • 依托单位:
国内基金
海外基金
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    孙华鑫
  • 依托单位:
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
  • 批准号:
    --
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    韩小建
  • 依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    孙华鑫
  • 依托单位: